Examined parameters | LM n = 107 | PCR n = 95 |
---|---|---|
Age (years) | 65 | 66 |
Median (range) | (38–88) | (40–88) |
Sex, number of patients (%) | Â | Â |
 Women | 41 (38.3%) | 37 |
 Men | 66 (61.7%) | 58 |
Tumour location*, number (%) | Â | Â |
 Right side | 24 (22.4%) | 22 |
 Left side | 83 (77.6%) | 73 |
Tumour location*, number (%) | Â | Â |
 Rectum | 45 (42.1%) | 40 |
 Colon | 62 (57.9%) | 55 |
TNM stage, number (%) | Â | Â |
 I | 18 (16.8%) | 18 |
 IIA | 36 (33.7%) | 33 |
 IIB | 0 | 0 |
 IIC | 1 (0.9%) | 0 |
 IIIA | 1 (0.9%) | 1 |
 IIIB | 28 (26.2%) | 23 |
 IIIC | 7 (6.5%) | 6 |
 IV | 16 (15%) | 14 |
Astler-Coller stage, number (%) | Â | Â |
 A | 3 (2,8%) | 3 |
 B1 | 15 (14%) | 15 |
 B2 | 36 (33.6%) | 33 |
 B3 | 1 (0.9%) | 0 |
 C1 | 2 (1.9%) | 1 |
 C2 | 32 (29.9%) | 28 |
 C3 | 2 (1.9%) | 1 |
 D | 16 (15%) | 14 |
Astler-Coller stage, number (%) | Â | Â |
 A + B | 55 (51.4%) | 51 |
 C + D | 52 (48.6%) | 44 |
Grade, number (%)** | Â | Â |
 G1 | 7 (6.7%) | 6 |
 G2 | 78 (74.3%) | 68 |
 G3 | 14 (13.3%) | 14 |
 Mucinosum | 6 (5.7%) | 6 |
Grade, number (%)** | Â | Â |
 G1 + G2 | 85 (81%) | 74 |
 G3 + mucinosum | 20 (19%) | 20 |